Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Change in Account Payables: 2010-2025

Historic Change in Account Payables for National Healthcare (NHC) over the last 16 years, with Q3 2025 value amounting to $1.3 million.

  • National Healthcare's Change in Account Payables rose 3673.04% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.8 million, marking a year-over-year decrease of 23457.18%. This contributed to the annual value of $6.3 million for FY2024, which is 18170.84% up from last year.
  • As of Q3 2025, National Healthcare's Change in Account Payables stood at $1.3 million, which was up 3673.04% from -$367000.0 recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Change in Account Payables ranged from a high of $10.7 million in Q3 2021 and a low of -$10.4 million during Q4 2021
  • Moreover, its 5-year median value for Change in Account Payables was $1.1 million (2024), whereas its average is -$105473.7.
  • The largest annual percentage gain for National Healthcare's Change in Account Payables in the last 5 years was 150119.76% (2021), contrasted with its biggest fall of 95204.58% (2021).
  • National Healthcare's Change in Account Payables (Quarter) stood at -$10.4 million in 2021, then surged by 76.13% to -$2.5 million in 2022, then surged by 209.58% to $2.7 million in 2023, then grew by 1.69% to $2.8 million in 2024, then tumbled by 53.49% to $1.3 million in 2025.
  • Its Change in Account Payables was $1.3 million in Q3 2025, compared to -$367000.0 in Q2 2025 and -$3.8 million in Q1 2025.